Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-04-18

Clinical Trial Update: Brilliant Blue Versus Indocyanine Green [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing Brilliant Blue dye versus Indocyanine Green for vitreoretinal surgery in macular pucker and macular hole. The current status of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brilliant Blue (Brilliant Blue G)
  • Indocyanine Green (Indocyanine Green)

Snippet

Sponsor: University of Cologne | Conditions: Macular Pucker, Macular Hole | Phase 3 | Status: UNKNOWN